Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling
Science Advances · 2025
DOI: 10.1126/sciadv.adn2528 ↗At a glance
Journal article in Science Advances, 2025. Written by Pawan K Singh and 11 co-authors. Institution: MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Major MEDLINE topics: Mitophagy, Signal Transduction, Protein Kinases, eIF-2 Kinase. Cited 15 times so far (Crossref); 52 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust, Medical Research Council.
Abstract (original language)
Loss-of-function mutations in the PINK1 kinase lead to early-onset Parkinson’s disease (PD). PINK1 is activated by mitochondrial damage to phosphorylate ubiquitin and Parkin, triggering mitophagy. PINK1 also indirectly phosphorylates Rab GTPases, such as Rab8A. Using an siRNA library targeting human Ser/Thr kinases in HeLa cells, we identified EIF2AK1 [heme-regulated inhibitor (HRI) kinase], a branch of the integrated stress response (ISR), as a negative regulator of PINK1. EIF2AK1 knockdown enhances mitochondrial depolarization–induced PINK1 stabilization and phosphorylation of ubiquitin and Rab8A. These results were confirmed in SK-OV-3, U2OS, and ARPE-19 cells. Knockdown of DELE1, an activator of EIF2AK1, produced similar effects. Notably, the ISR inhibitor ISRIB also enhanced PINK1 activation. In human cells with mito-QC mitophagy reporters, EIF2AK1 knockdown or ISRIB treatment increased PINK1-dependent mitophagy without affecting deferiprone-induced mitophagy. These findings suggest that the DELE1-EIF2AK1 ISR pathway is a negative regulator of PINK1-dependent mitophagy. Further evaluation in PD-relevant models is needed to assess the therapeutic potential of targeting this pathway.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
- Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
ORCID profiles: Pawan K Singh, Shalini Agarwal, Léa P Wilhelm, Giada Becchi, Andrew Keenlyside, Thomas Macartney, Rachel Toth, Adrien Rousseau, Glenn R Masson, Ian G Ganley, Miratul M K Muqit
Funding
- Wellcome Trust
- Medical Research Council
Cite
APA
Singh, P. K., Agarwal, S., Volpi, I., Wilhelm, L. P., Becchi, G., Keenlyside, A., Macartney, T., Toth, R., Rousseau, A., Masson, G. R., Ganley, I. G., & Muqit, M. M. K. (2025). Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling. Science Advances. https://doi.org/10.1126/sciadv.adn2528
Vancouver
Singh PK, Agarwal S, Volpi I, Wilhelm LP, Becchi G, Keenlyside A, et al. Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling. Science Advances. 2025. doi:10.1126/sciadv.adn2528
BibTeX
@article{Singh2025,
author = {Singh, Pawan K and Agarwal, Shalini and Volpi, Ilaria and Wilhelm, Léa P and Becchi, Giada and Keenlyside, Andrew and Macartney, Thomas and Toth, Rachel and Rousseau, Adrien and Masson, Glenn R and Ganley, Ian G and Muqit, Miratul M K},
title = {Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adn2528}
}
EUVIMED